Meanwhile, drugmaker Moderna MRNA said late on Thursday Moderna MRNA said late on Thursday that its COVID-19 vaccine had the potential to confer longer-term immunity, and that it expects to have 20 million vaccine doses available in the U.S. this year. There were lots of unconnected dots coupled with inconsistency and discouraging profits till I subscribed to
this premium program, they really helped me connect stock trading dots fast enough, and I am still learning with them